| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Wen Hsuan Hsieh is Director at LIDR and has filed Form 4s across 3 companies. Wen Hsuan Hsieh's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $16.4M at current prices.
The biggest single holding is LIDR (~$15.8M) as Director. The LIDR filings lean toward selling, a net 643,289 shares.
Wen Hsuan Hsieh has 12 Form 4 filings on record from September 2021 to June 2026, across 3 companies: Director at Ambiq Micro (AMBQ), 2025–2026; Director at Amprius Technologies (AMPX), 2022–2026; Director at AEye (LIDR), 2021–2023.
The 14 reported transactions were 7 stock awards, 3 open-market sales, 2 option exercises and 1 conversion, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $7.8M.
The largest open-market sale was 413,146 shares of AMPX at an average $18.44 on March 12, 2026, about $7.6M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.